Xencor's Grant

Xencor raised a round of funding on June 19, 2001. Investors include National Science Foundation.

Xencor engineers biotherapeutics using its Protein Design Automation technology platform, and is a provider in the field of antibody engineering to significantly improve antibody half-life, immune-reg…

Articles about Xencor's Grant: